Stay updated on KD025 in Diffuse Cutaneous Systemic Sclerosis Clinical Trial
Sign up to get notified when there's something new on the KD025 in Diffuse Cutaneous Systemic Sclerosis Clinical Trial page.

Latest updates to the KD025 in Diffuse Cutaneous Systemic Sclerosis Clinical Trial page
- Check3 days agoChange DetectedNo additions or deletions were detected on the Study Details page for NCT03919799; the content appears unchanged. The page continues to show the protocol, enrollment numbers, locations, and dates as before.SummaryDifference0.3%

- Check10 days agoNo Change Detected
- Check31 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.SummaryDifference0.8%

- Check39 days agoChange DetectedThe page has been updated to version v3.1.0 and several related topics (MedlinePlus topics on drug safety, counterfeit drugs, pharmaceutical preparations, and substandard drugs) have been removed.SummaryDifference0.1%

- Check53 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. Overall, a minor release with no broader content changes.SummaryDifference0.0%

- Check60 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.0%

- Check67 days agoChange DetectedThe web page has been updated to include new information about drug safety and publications related to belumosudil and diffuse cutaneous systemic sclerosis, while some previous location and terminology details have been removed.SummaryDifference2%

Stay in the know with updates to KD025 in Diffuse Cutaneous Systemic Sclerosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KD025 in Diffuse Cutaneous Systemic Sclerosis Clinical Trial page.